Germinal centers (brown) are abnormal in mice lacking miR-155 (bottom).
T he fi rst microRNA (miRNA) knockout mice reveal that these tiny RNAs have sizeable power over mammalian physiology, as shown by three new reports.
Rather than coding for proteins, miRNAs decrease protein levels by binding to their mRNA targets. Since their discovery in worms, researchers have wondered whether miRNAs simply fi netune the genome's work or have largescale effects of their own.
The fi rst reports of mice lacking specifi c miRNAs suggest their effects are wide and strong. Antony Rodriguez, Allan Bradley (Sanger Institute, London, UK), and colleagues knocked out the gene coding for miR-155, which is active in the immune system and is up-regulated in lymphomas. The mice had defective T cell responses, were unable to fi ght off infection, and displayed lung tissue scarring seen in autoimmune diseases.
The same miRNA was also deleted by To-Ha Thai, Klaus Rajewsky (Harvard Medical School, Boston, MA), and colleagues. They found that these mice also had B cell defects. In normal animals, antigen-activated B cells proliferate in the germinal centers (GCs), which generate high-affi nity antibodies and control immune memory. But these GC reactions were blunted in the knockouts, whose B cells failed to produce the necessary cytokines. Overexpressing miR-155, in contrast, enhanced the GC reaction.
Moving out of immunity and into the heart, Yong Zhao, Deepak Srivastava (Gladstone Institutes and University of California, San Francisco, CA), and colleagues knocked out miR-1-2, a regulator of cardiogenesis. The gene is one of two that encode identical mature miRNAs, yet even just cutting total miR-1 levels in half produced errors in cell cycle regulation and electroconductance in heart cells. The group found that the target mRNA's secondary structure must be open enough for the miRNA to attach. "If you imagine the mRNA balled up, even if there's great sequence matching, [the miRNA] can't get to it," says Srivastava.
As additional knockouts emerge, in vivo studies will clarify which miRNAs have subtle or bold effects, the researchers note. The fact that individual miRNAs have grand effects puts them on the radar as a major regulatory system, Rajewsky says. "Somehow we've all mainly been thinking about transcription factors." To begin dividing, mitotic cells round up into tight spheres, thus decreasing their surface area. But where does the extra membrane go, and where does it come from when it's time to expand again? Because the Golgi apparatus is disabled until the end of division, researchers assumed that cell traffi ckingincluding endocytosis-grinds to a halt. EM studies suggested instead that accordion-like folds at the cell surface took up the membrane slack.
In their new report, the researchers measured membrane decrease and recovery during mitosis using live-cell fl uorescence imaging. They found that endocytosis is not shut off during division. Clathrin-coated vesicles formed at a steady rate, and the uptake of transferrin remained normal. Previous studies missed the ongoing endocytosis, says Kirchhausen, because they did not correct for surface area changes. When the duo blocked endocytosis, cells failed to round up and subsequently divided incorrectly. In turn, blocking endosomal fusion at anaphase prevented cell membrane recovery. But inhibiting the Golgi apparatus had no effect, suggesting that recovery relies not on new membrane but on membrane reservoirs that accumulate within the cell.
Recycling during mitosis may help cells stay symmetrical as they divide, says Kirchhausen. The group is now testing whether the mechanism exists in asymmetrically dividing cells. Also, he notes, their results implicate calcium as a regulator of the mitotic recycling, perhaps akin to its role in endosomal fusion in wound healing.
